Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases

Abstract Disease-modifying therapies (DMTs) are widely used in neuroimmunological diseases such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Although these treatments are known to predispose patients to infections and affect their responses to vaccination, little is...

Full description

Bibliographic Details
Main Authors: Meng Wang, Adeline Dehlinger, Camila Fernández Zapata, Maya Golan, Gerardina Gallaccio, Leif E. Sander, Stephan Schlickeiser, Desiree Kunkel, Tanja Schmitz-Hübsch, Birgit Sawitzki, Arnon Karni, Julian Braun, Lucie Loyal, Andreas Thiel, Judith Bellmann-Strobl, Friedemann Paul, Lil Meyer-Arndt, Chotima Böttcher
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-43553-z